CNS Co (TSE:4076) 1-Year Sharpe Ratio: 1.43 (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4076 CNS Co Ltd TSE:4076
85 GF Score
Price 円2,012.00
GF Value 円1,873.31
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is CNS Co 1-Year Sharpe Ratio?

CNS Co TSE:4076 +1.11% 85 1-Year Sharpe Ratio is 1.43 as of Aug. 30, 2026. GuruFocus rates TSE:4076 with a GF Score™ of 85/100 and a GF Value™ of 円1,873.31 (Fairly Valued). The stock has 5 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-30), CNS Co's 1-Year Sharpe Ratio is 1.43.

CNS Co  (TSE:4076) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

CNS Co 1-Year Sharpe Ratio Related Terms

TSE:4076 vs IBM, ACN, FISV: 1-Year Sharpe Ratio Comparison

For the Information Technology Services subindustry, CNS Co's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNS Co 1-Year Sharpe Ratio vs Software Industry

For the Software industry and Technology sector, CNS Co's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where CNS Co's 1-Year Sharpe Ratio falls into.


TSE:4076
85GF Score
CNS Co Ltd TSE:4076
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CNS Co 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 1.43 mean?
CNS Co (TSE:4076) has a 1-Year Sharpe Ratio of 1.43 as of Aug. 30, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for CNS Co and its competitors.
Is CNS Co's 1-Year Sharpe Ratio too high?
CNS Co's current 1-Year Sharpe Ratio is 1.43. Overall, CNS Co has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CNS Co's 1-Year Sharpe Ratio compare to IBM and ACN?
CNS Co's 1-Year Sharpe Ratio of 1.43 can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Software company?
A good 1-Year Sharpe Ratio depends on the Software industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for CNS Co and its competitors. CNS Co's current 1-Year Sharpe Ratio is 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CNS Co stock overvalued right now?
Based on GuruFocus' analysis, CNS Co (TSE:4076) is currently considered Fairly Valued. The stock's GF Value™ is 円1,873.31, compared to a current price of 円2,012.00 — trading 7.4% above its estimated fair value. The current 1-Year Sharpe Ratio is 1.43. CNS Co's overall GF Score™ is 85/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For CNS Co (TSE:4076), the current 1-Year Sharpe Ratio is 1.43 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CNS Co (TSE:4076) Overvalued in 2026?

Based on GuruFocus' analysis, CNS Co stock appears to be overvalued. The current stock price of 円2,012.00 is trading 7.4% above its estimated GF Value™ of 円1,873.31. GuruFocus considers CNS Co to be Fairly Valued.

Key valuation signals for TSE:4076:

  • 1-Year Sharpe Ratio: 1.43
  • GF Value™: 円1,873.31 vs. price of 円2,012.00 (7.4% above fair value)
  • GF Score™: 85/100 with 5 warning signs

No single metric tells the full story. See the TSE:4076 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CNS Co Business Description

Address 1-5-5 Ebisu Minami, 9th Floor, JR Ebisu Building, Shibuya-ku, Tokyo, JPN, 150-0022
CNS Co Ltd is an information technology solutions company engaged in providing system engineering services. The company offers various solutions to its clients such as consulting services related to digital transformation, data analysis solutions, business system integration, and the implementation, construction, and operation of optimal system infrastructure.
85GF Score

Get the complete analysis for TSE:4076

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,012.00
Price
円1,873.31
GF Value